Clinical Trial Update: A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906 [Phase 1]

View source ↗

Summary

Phase 1 trial update on how BI 456906 is absorbed and processed in healthy individuals and in people with liver disease. It also evaluates tolerability of diffe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease
• Obesity

Drugs mentioned

• BI 456906

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy, Liver Diseases | Phase 1 | Status: COMPLETED